Surprisingly, Rovedatti et al. (2009) reported that production of IFN-γ in inflamed mucosa of patients with ulcerative colitis and Crohn’s disease was equivalent to normal mucosa and that TGF-β inhibited its production, but did not downregulate production of IL-17. This evidence concerns the gene IL17A and Crohn disease.